Showing results (11-20 of 26) with videos related to

Sort By:
Pageof 3
Current Medical Research and Opinion|July 9, 2021
Epidemiology of skin event rates among users of pumps for the subcutaneous administration of drugs for chronic conditionsSusan S Jick, Denise M Oleske, Rebecca Persson, et al.
Clinical Epidemiology|December 21, 2023
Presence of Breast Cancer Information Recorded in United Kingdom Primary Care Databases: Comparison of CPRD Aurum and CPRD GOLD (Companion Paper 1)Katrina Wilcox Hagberg, Catherine Vasilakis-Scaramozza, Rebecca Persson, et al.
Pharmacoepidemiology and Drug Safety|February 17, 2025
Validation of Clinical Practice Research Datalink (CPRD) Aurum Mother-Baby LinkCatherine Vasilakis-Scaramozza, Rebecca Persson, George Kafatos, et al.
BMJ (Clinical Research Ed.)|September 24, 2016
Risk of erectile dysfunction associated with use of 5-α reductase inhibitors for benign prostatic hyperplasia or alopecia: population based studies using the Clinical Practice Research DatalinkKatrina Wilcox Hagberg, Hozefa A Divan, Rebecca Persson, et al.
Clinical Epidemiology|December 21, 2023
Use of the CPRD Aurum Database: Insights Gained from New Data Quality AssessmentsSusan Jick, Catherine Vasilakis-Scaramozza, Rebecca Persson, et al.
Clinical Epidemiology|December 21, 2023
Correctness and Completeness of Breast Cancer Diagnoses Recorded in UK CPRD Aurum and CPRD GOLD Databases: Comparison to Hospital Episode Statistics and Cancer Registry (Companion Paper 2)Katrina Wilcox Hagberg, Catherine Vasilakis-Scaramozza, Rebecca Persson, et al.
Clinical Epidemiology|December 21, 2023
Comparison of Rheumatoid Arthritis Information Recorded in UK CPRD Aurum and CPRD GOLD Databases (Companion Paper 3)Catherine Vasilakis-Scaramozza, Katrina Wilcox Hagberg, Rebecca Persson, et al.
Clinical Epidemiology|May 10, 2022
Presence of Codes for Indication for Use in Clinical Practice Research Datalink Aurum: An Assessment of Benign Prostatic Hyperplasia TreatmentsRebecca Persson, Katrina Wilcox Hagberg, Catherine Vasilakis-Scaramozza, et al.
Pharmacoepidemiology and Drug Safety|September 28, 2020
CPRD Aurum database: Assessment of data quality and completeness of three important comorbiditiesRebecca Persson, Catherine Vasilakis-Scaramozza, Katrina Wilcox Hagberg, et al.
Pharmacoepidemiology and Drug Safety|October 17, 2022
Quality of rheumatoid arthritis recording in United Kingdom Clinical Practice Research Datalink AurumCatherine Vasilakis-Scaramozza, Katrina Wilcox Hagberg, Rebecca Persson, et al.
Pageof 3